Search Results 281-290 of 19383 for B cell lymphomas

  1. Cancer Treatment Clinical Trials - Mayo Clinic Research

    ... B-cell lymphomas who have failed 1-2 prior lines of therapy. The primary objectives are to determine the maximum tolerated dose (MTD) or highest protocol ...

  2. Clinical trials - Oncology (Medical)

    ... B-cell lymphoma 2 (BCL2) inhibitor. MC1733, Phase I Trial of Intratumoral Administration of a Measles Virus Derivative Expressing the Helicobacter pylori ...

  3. Major advance in use of CAR-T cell therapy to treat solid tumors - Mayo Clinic

    ... B-cell lymphomas and leukemias. But scientists have faced unique challenges developing a CAR-T cell therapy that targets solid tumors. CAR-T cells are ...

  4. Clinical trials - Oncology (Medical)

    ... B-cell Lymphoma (R/R DLBCL). Rochester, Minn. Study B9991011 is a multi-center, international, randomized, open label, 2 component (Phase 1b followed by ...

  5. A Study of Glofitamab and Lenalidomide in People With Mantle Cell Lymphoma - Mayo Clinic

    A Study of Glofitamab and Lenalidomide in People With Mantle Cell Lymphoma ... -Active hepatitis B or C, as defined below: -HBV ... -CD4+ T cell count ≥ 250 cells/ ...

  6. Clinical trials - Oncology (Medical)

    ... B-cell lymphoma 2 (BCL2) inhibitor. MC1733, Phase I Trial of Intratumoral Administration of a Measles Virus Derivative Expressing the Helicobacter pylori ...

  7. Mayo Clinic offers unique CLL testing and care

    Immunoglobin heavy locus (IGH) somatic hypermutation analysis, B-cell chronic lymphocytic leukemia (B CLL ) ... cell lymphoma, which affects 5% to 15% of patients ...

  8. AZD0486 As Monotherapy In Participants With Relapsed/Refractory (R/R) B-cell NHL - Mayo Clinic

    AZD0486 As Monotherapy In Participants With Relapsed/Refractory (R/R) B-cell NHL · Overview · Participation eligibility · Participating Mayo Clinic locations · More ...

  9. Cancer Videos - Medical Professionals - Mayo Clinic

    Large B-cell lymphoma: Innovative treatment and care plans. Grzegorz S. Nowakowski, M.D., hematologist and oncologist at Mayo Clinic Comprehensive Cancer Center ...

  10. A Study to Provide Access to CTL019 Out of Specification Managed Access Program (MAP) for ALL or DLBCL Patients - Mayo Clinic

    ... b-cell lymphoma (DLBCL) patients with out of specification leukapheresis product and/or manufactured tisagenlecleucel out of specification for commercial ...